Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity.

Oikawa T, Otsuka Y, Onodera Y, Horikawa M, Handa H, Hashimoto S, Suzuki Y, Sabe H.

Sci Rep. 2018 Jan 25;8(1):1595. doi: 10.1038/s41598-018-20043-7.

2.

Epigenetic Alterations in Human Papillomavirus-Associated Cancers.

Soto D, Song C, McLaughlin-Drubin ME.

Viruses. 2017 Sep 1;9(9). pii: E248. doi: 10.3390/v9090248. Review.

3.

The "readers" of unacetylated p53 represent a new class of acidic domain proteins.

Wang D, Kon N, Tavana O, Gu W.

Nucleus. 2017 Jul 4;8(4):360-369. doi: 10.1080/19491034.2017.1313939. Epub 2017 Apr 13.

4.

Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.

Wang F, Marshall CB, Ikura M.

Intrinsically Disord Proteins. 2015 Jun 3;3(1):e1056906. doi: 10.1080/21690707.2015.1056906. eCollection 2015. Review.

5.

The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.

Zhang J, Vlasevska S, Wells VA, Nataraj S, Holmes AB, Duval R, Meyer SN, Mo T, Basso K, Brindle PK, Hussein S, Dalla-Favera R, Pasqualucci L.

Cancer Discov. 2017 Mar;7(3):322-337. doi: 10.1158/2159-8290.CD-16-1417. Epub 2017 Jan 9.

6.

microRNA-22 attenuates myocardial ischemia-reperfusion injury via an anti-inflammatory mechanism in rats.

Yang J, Fan Z, Yang J, Ding J, Yang C, Chen L.

Exp Ther Med. 2016 Nov;12(5):3249-3255. Epub 2016 Oct 4.

7.

The human papillomavirus E7 oncoprotein as a regulator of transcription.

Songock WK, Kim SM, Bodily JM.

Virus Res. 2017 Mar 2;231:56-75. doi: 10.1016/j.virusres.2016.10.017. Epub 2016 Nov 8. Review.

8.

Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.

Wang J, Yang ZH, Chen H, Li HH, Chen LY, Zhu Z, Zou Y, Ding CC, Yang J, He ZW.

BMC Cancer. 2016 Mar 31;16:257. doi: 10.1186/s12885-016-2291-4.

9.

Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.

Krois AS, Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1853-62. doi: 10.1073/pnas.1602487113. Epub 2016 Mar 14.

10.

Unique epigenetic influence of H2AX phosphorylation and H3K56 acetylation on normal stem cell radioresponses.

Jacobs KM, Misri S, Meyer B, Raj S, Zobel CL, Sleckman BP, Hallahan DE, Sharma GG.

Mol Biol Cell. 2016 Apr 15;27(8):1332-45. doi: 10.1091/mbc.E16-01-0017. Epub 2016 Mar 3.

11.

Modeling the interplay between the HIF-1 and p53 pathways in hypoxia.

Zhou CH, Zhang XP, Liu F, Wang W.

Sci Rep. 2015 Sep 8;5:13834. doi: 10.1038/srep13834.

12.

Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis.

Hiraki M, Hwang SY, Cao S, Ramadhar TR, Byun S, Yoon KW, Lee JH, Chu K, Gurkar AU, Kolev V, Zhang J, Namba T, Murphy ME, Newman DJ, Mandinova A, Clardy J, Lee SW.

Chem Biol. 2015 Sep 17;22(9):1206-16. doi: 10.1016/j.chembiol.2015.07.016. Epub 2015 Aug 27.

13.

Exome Sequencing Identification of EP300 Mutation in a Proband with Coloboma and Imperforate Anus: Possible Expansion of the Phenotypic Spectrum of Rubinstein-Taybi Syndrome.

Masuda K, Akiyama K, Arakawa M, Nishi E, Kitazawa N, Higuchi T, Katou Y, Shirahige K, Izumi K.

Mol Syndromol. 2015 Jul;6(2):99-103. doi: 10.1159/000375542. Epub 2015 Mar 3.

14.

Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25.

Landrieu I, Verger A, Baert JL, Rucktooa P, Cantrelle FX, Dewitte F, Ferreira E, Lens Z, Villeret V, Monté D.

Nucleic Acids Res. 2015 Aug 18;43(14):7110-21. doi: 10.1093/nar/gkv650. Epub 2015 Jun 29.

15.

Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.

Haery L, Thompson RC, Gilmore TD.

Genes Cancer. 2015 May;6(5-6):184-213. Review.

16.

Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.

Ali A, Bhatti MZ, Shah AS, Duong HQ, Alkreathy HM, Mohammad SF, Khan RA, Ahmad A.

J Biol Chem. 2015 Aug 28;290(35):21336-51. doi: 10.1074/jbc.M114.635730. Epub 2015 Apr 24.

17.

Protein lysine acetylation by p300/CBP.

Dancy BM, Cole PA.

Chem Rev. 2015 Mar 25;115(6):2419-52. doi: 10.1021/cr500452k. Epub 2015 Jan 16. Review. No abstract available. Erratum in: Chem Rev. 2016 Jul 27;116(14 ):8314.

18.

p53 Acetylation: Regulation and Consequences.

Reed SM, Quelle DE.

Cancers (Basel). 2014 Dec 23;7(1):30-69. doi: 10.3390/cancers7010030. Review.

19.

The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.

Jansma AL, Martinez-Yamout MA, Liao R, Sun P, Dyson HJ, Wright PE.

J Mol Biol. 2014 Dec 12;426(24):4030-4048. doi: 10.1016/j.jmb.2014.10.021. Epub 2014 Nov 1.

20.

KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes.

Koh DI, Han D, Ryu H, Choi WI, Jeon BN, Kim MK, Kim Y, Kim JY, Parry L, Clarke AR, Reynolds AB, Hur MW.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15078-83. doi: 10.1073/pnas.1318780111. Epub 2014 Oct 6.

Supplemental Content

Support Center